Dallas—Peloton Therapeutics, which is developing small molecule drugs to treat cancer, announced Wednesday that it has raised $150 million in a Series E funding round.
The new financing was led by RA Capital Management and was joined by new investors,... Read more »
Menlo Ventures, like many other Silicon Valley venture capital firms, has at times looked for big returns from spotting early-stage companies with great promise. But as it launches a new $500 million fund, it plans to hunt for companies that... Read more »
TechTown Detroit, Wayne State University, and NextEnergy have formed a new consortium to advance the Motor City’s tech ecosystem and apply new innovations to tough civic challenges.
Called Detroit Urban Solutions, the consortium will focus primarily on mobility, digital... Read more »
San Antonio—GenCure, a subsidiary of life sciences nonprofit BioBridge Global, expects to open a biomanufacturing laboratory this year at a new “innovation center” that’s being developed by VelocityTX in San Antonio.
GenCure is a regenerative medicine-focused organization that accepts... Read more »
Rivian, a Plymouth, MI-based company getting set to launch sales of its brawny, high-end electric vehicles, will be able to give those efforts a boost after raising $700 million in new funding. Amazon (NASDAQ: AMZN) led the investment in... Read more »
It wasn’t the monthly bank statement that made Nasuni, a Boston-based cloud storage technology startup, run out and raise $25 million in venture funding.
The company had yet to burn through even half of the $38 million it raised in September... Read more »
Digital Guardian, a cybersecurity business focused on data loss prevention, has tapped a CA Technologies executive to lead the Waltham, MA-based company several months after the departure of CEO Ken Levine.
Mordecai “Mo” Rosen, who most recently managed CA Technologies’ cybersecurity... Read more »
It takes a healthy imagination to pinpoint all the cybersecurity risks baked into today’s Internet-connected, cloud-managed, Web-hungry world—let alone even start to plan for the vulnerabilities, attack strategies, and potent defenses for the future.
On April 8, Xconomy is bringing together... Read more »
The first-ever marketed medicine for the fatty liver disease known as nonalcoholic steatohepatitis, or NASH, could be on the horizon. The data, from a closely watched drug known as obeticholic acid, aren’t perfect. But they are nonetheless expected by the drug’s... Read more »
Stealth BioTherapeutics has popped up on the radar with a $78 million IPO to fund clinical trials for drugs treating rare mitochondrial disorders.
Shares of Stealth Bio (NASDAQ: MITO) made their stock market debut Friday at $12 apiece, which was... Read more »
—Pinpoint, an Austin startup that makes analytics tool to measure software engineering’s contribution to businesses, has raised $13.5 million in a Series A funding round led by Bessemer Venture Partners. Other investors include Storm Ventures, Boldstart Ventures, Bloomberg Beta, Slack... Read more »
Bayer has just reclaimed some rights to two drugs from Loxo Oncology, which means it’s going to take more work for Loxo’s buyer, Eli Lilly, to justify the $8 billion it is paying for the company.
Lilly (NYSE: LLY) this... Read more »
[Updated 6:35 p.m. PT. See below.] Section 32, a venture capital firm headquartered near San Diego that launched in 2017 with a $151 million fund, has had a big month.
The firm, based in San Diego’s coastal Cardiff-by-the-Sea community, was started... Read more »